Lisata Therapeutics logo

Lisata Therapeutics Share Price Today

(NASDAQ: LSTA)

Lisata Therapeutics share price is $2.37 & ₹206.12 as on 6 Mar 2025, 2.30 'hrs' IST

$2.37

0.22

(10.23%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Lisata Therapeutics share price in Dollar and Rupees. Guide to invest in Lisata Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lisata Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Lisata Therapeutics share price movements

  • Today's Low: $2.15
    Today's High: $2.42

    Day's Volatility :11.16%

  • 52 Weeks Low: $2.14
    52 Weeks High: $4.20

    52 Weeks Volatility :49.05%

Lisata Therapeutics (LSTA) Returns

PeriodLisata Therapeutics IncIndex (Russel 2000)
3 Months
-20.37%
0.0%
6 Months
-34.25%
0.0%
1 Year
-30.47%
0.0%
3 Years
-65.6%
-11.6%

Lisata Therapeutics (LSTA) Key Statistics

in dollars & INR

Previous Close
$2.15
Open
$2.05
Today's High
$2.42
Today's Low
$2.15
Market Capitalization
$18.0M
Today's Volume
$1.5K
52 Week High
$4.2
52 Week Low
$2.14
Revenue TTM
$0.0
EBITDA
$-23.3M
Earnings Per Share (EPS)
$-2.42
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-48.15%

How to invest in Lisata Therapeutics Stock (LSTA) from India?

It is very easy for Indian residents to invest directly in Lisata Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lisata Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lisata Therapeutics or LSTA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lisata Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lisata Therapeutics shares which would translate to 0.367 fractional shares of Lisata Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lisata Therapeutics, in just a few clicks!

Returns in Lisata Therapeutics (LSTA) for Indian investors in Rupees

The Lisata Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lisata Therapeutics investment value today

Current value as on today

₹81,662

Returns

₹18,338

(-18.34%)

Returns from Lisata Therapeutics Stock

₹23,301 (-23.3%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Lisata Therapeutics (LSTA)

-64%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Lisata Therapeutics Stock from India on INDmoney has decreased by -64% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Lisata Therapeutics

  • BML Capital Management LLC

    3.39%

  • Vanguard Group Inc

    2.22%

  • Renaissance Technologies Corp

    1.21%

  • BlackRock Inc

    0.67%

  • Geode Capital Management, LLC

    0.67%

  • Dimensional Fund Advisors, Inc.

    0.30%

Analyst Recommendation on Lisata Therapeutics

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Lisata Therapeutics(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Lisata Therapeutics Stock (LSTA)

What analysts predicted

Upside of 617.3%

Target:

$17.00

Current:

$2.37

Insights on Lisata Therapeutics Stock (Ticker Symbol: LSTA)

  • Price Movement

    In the last 7 days, LSTA stock has moved down by -10.0%
  • LSTA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 93.4%

Lisata Therapeutics Technicals Summary

Sell

Neutral

Buy

Lisata Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Lisata Therapeutics (LSTA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lisata Therapeutics Inc logo
-16.67%
-34.25%
-30.47%
-65.6%
-65.6%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lisata Therapeutics Inc logo
NA
NA
NA
-2.54
-0.48
-0.3
NA
4.05
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lisata Therapeutics Inc logo
Buy
$18.0M
-65.6%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Organization
Lisata Therapeutics
Employees
25
CEO
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
Industry
Miscellaneous

Management People of Lisata Therapeutics

NameTitle
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
President, CEO & Director
Dr. Kristen K. Buck M.D.
Executive VP of R&D and Chief Medical Officer
Mr. James Nisco
Senior VP of Finance, Treasurer, CAO & Principal Financial and Accounting Officer
Mr. Gregory S. Berkin
Chief Information & Data Protection Officer
Mr. John D. Menditto
Vice President of Investor Relations & Corporate Communications
Ms. Gail Holler
Vice President of Human Resources
Dr. William K. Sietsema Ph.D.
Vice President of Global Regulatory Affairs

Important FAQs about investing in LSTA Stock from India :

What is Lisata Therapeutics share price today?

Lisata Therapeutics share price today stands at $2.37, Open: $2.05 ; Previous Close: $2.15 ; High: $2.42 ; Low: $2.15 ; 52 Week High: $4.20 ; 52 Week Low: $2.14.

The stock opens at $2.05, after a previous close of $2.15. The stock reached a daily high of $2.42 and a low of $2.15, with a 52-week high of $4.20 and a 52-week low of $2.14.

Can Indians buy Lisata Therapeutics shares?

Yes, Indians can invest in the Lisata Therapeutics (LSTA) from India.

With INDmoney, you can buy Lisata Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Lisata Therapeutics at zero transaction cost.

How can I buy Lisata Therapeutics shares from India?

It is very easy to buy Lisata Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lisata Therapeutics (LSTA) be purchased?

Yes, you can buy fractional shares of Lisata Therapeutics with INDmoney app.

What are the documents required to start investing in Lisata Therapeutics stocks?

To start investing in Lisata Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Lisata Therapeutics Stock (LSTA)?

Today’s highest price of Lisata Therapeutics (LSTA) is $2.42.

Today’s lowest price of Lisata Therapeutics (LSTA) is $2.15.

What is today's market capitalisation of Lisata Therapeutics?

Today's market capitalisation of Lisata Therapeutics LSTA is 18.0M

What is the 52 Week High and Low Range of Lisata Therapeutics Stock (LSTA)?

  • 52 Week High

    $4.20

  • 52 Week Low

    $2.14

What are the historical returns of Lisata Therapeutics (LSTA)?

  • 1 Month Returns

    -16.67%

  • 3 Months Returns

    -34.25%

  • 1 Year Returns

    -30.47%

  • 5 Years Returns

    -65.6%

Who is the Chief Executive Officer (CEO) of Lisata Therapeutics ?

Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D. is the current Chief Executive Officer (CEO) of Lisata Therapeutics.